Abstract
More than 30% of epilepsy patients remain refractory to pharmacotherapy. Combined administration of AEDs or the application of novel AEDs is a therapeutic option especially when surgical treatment cannot be offered. The newer AEDs offer new mechanisms of action and more favourable safety profiles than the older AEDs. Lacosamide (LCM) is one of the third generation AEDs approved for adjunctive use in partial-onset seizures. Patients with epilepsy frequently experience cognitive dysfunctions. Because antiepileptic drugs (AEDs) are the major therapeutic modality for epilepsy, the adverse effects of AEDs on cognition are important.
Objectives This study was conducted to obtain reliable data on the cognitive adverse effects of lacosamide in Indian population.
METHODOLOGY An open labelled prospective observational study in 22 patients who suffered from localization related epilepsy.
Results Average Initial seizure frequency per month was 3.56 (SD 2.58) and median frequency 2.5 seizures per month. Range being 1-8 per month. At the final followup at 6months, only 2 persons experienced seizure and that too only single episodes. The difference in frequency is statistically significant (Wilcoxon Signed Ranks TestP <0.001). All the pre and post lacosamide cognition scores showed statistically significant positive correlation in this study.
Conclusion Excellent seizure control is observed in patients with refractory localization related epilepsy treated with lacosamide. Also, lacosamide has no serious adverse effects or drug interactions. In this study, it is observed that unlike many AEDs, lacosamide contributed to significant improvement in cognition and can improve the quality of life in such patients.
Key points Excellent seizure control is observed in patients with refractory localization related epilepsy treated with lacosamide. Lacosamide has no serious adverse effects or drug interactions. In the above study, it is observed that unlike many AEDs, lacosamide contributed to significant improvement in cognition and can improve the quality of life in such patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nil
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Ethics Committee, Government Medical College, Thiruvananthapuram, Kerala, India
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations Funding: Nil
Conflicts of interest/Competing interests : Nil
Availability of data and material : ‘Not applicable’
Code availability : ‘Not applicable’
Data collection : Dr Sophia B Modi, Dr Thomas Iype and Mrs Reeja Rajan.
Formal data analysis: Dr Libu GK
Writing – original draft: Dr Sophia B Modi
Writing – review & editing: Dr Asha S, Dr Sophia B Modi, Dr Thomas Iype
All authors read and approved the final manuscript.
Author Affiliation: Government Medical college, Thiruvananthapuram, Kerala, India
Ethics approval : Ethics committee clearance was obtained, informed consent was obtained from each subject / guardian/ relative and confidentiality and anonymity of the patient’s information were maintained.
Consent to participate : Informed consent was obtained from each subject / guardian/ relative
Consent for publication : Informed consent was obtained from each subject / guardian/ relative
Data Availability
No external datasets or supplementary material online